PLUS THERAPEUTICS, INC.
For the period ended Dec 31, 2025. Filed Mar 12, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 12, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits, Financial Statement Schedules
(a) (1) Financial Statements.
The responses to this portion of Item 15 are set forth under Part II, Item 8 above. The following documents statements are filed as part of this report:
Balance Sheets — December 31, 2025 and 2024
Statements of Operations — December 31, 2025 and 2024
Statements of Stockholders’ Equity (Deficit) — December 31, 2025 and 2024
Statements of Cash Flows — December 31, 2025 and 2024
Notes to Financial Statements
(a) (2) Financial Statement Schedules.
None.
(a) (3) Exhibits.
List of Exhibits required by Item 601 of Regulation S-K. See Item 15(b) below.
(b) Exhibits.
The exhibits listed in the accompanying “Exhibit Index” are filed, furnished or incorporated by reference as part of this Annual Report, as indicated.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.